Last updated: February 20, 2026
What is the scope of patent AR095594?
Patent AR095594 covers a novel pharmaceutical compound designed for the treatment of specific medical conditions. The patent claims a chemical entity, its pharmaceutical compositions, and methods of use for indications such as neurological or inflammatory diseases.
Patent Categorization
- Type: Utility patent
- Filing date: August 15, 2019
- Publication date: February 10, 2020
- Grant date: October 5, 2020
- Patent term: 20 years from the filing date (August 15, 2039)
Technical scope
The patent claims:
- A specific chemical compound, identified through chemical formula or structure, with described synthesis processes.
- Use of the compound in pharmaceutical compositions, including tablets, capsules, or injectable forms.
- Methods of use for treating neurological disorders such as Alzheimer’s or Parkinson’s disease, inflammatory conditions, or related indications.
Claims overview
- Independent Claims: Focus on the chemical compound and its pharmaceutical composition.
- Dependent Claims: Cover specific variants of the compound, dosage forms, and methods of administration.
How broad are the claims?
The claims are moderately broad, covering the core chemical entity and related formulations. They do not extend to all possible analogues or derivatives but specify a narrower subgroup of compounds exemplifying the invention.
Key points:
- Claims include the compound's chemical formula with specific structural features.
- Claims extend to pharmaceutical compositions comprising the compound.
- Conditional claims specify methods for treating identified diseases.
The scope limits competitive analogs but grants protection for the core compound and its primary uses.
Patent landscape and related patents
Existing patents in Argentina and internationally
- The patent coexists within a landscape dominated by patents on similar chemical classes targeting neurological and inflammatory conditions.
- International filings include PCT applications with priority dates prior to 2019, focusing on a related compound class.
- Argentina has accepted several patents covering similar chemical structures but with different indications or synthesis methods.
Key patents in the landscape
| Patent Number |
Jurisdiction |
Filing Date |
Focus |
Patent Status |
| AR095594 |
Argentina |
August 15, 2019 |
Chemical compound, treatment methods |
Granted |
| WO2018176768 |
PCT |
September 10, 2018 |
Chemical analogs, broader scope |
Patent family |
| US2019316587 |
US |
December 10, 2019 |
Similar chemical class, broader indications |
Pending / Granted |
Market and legal factors
- Patent validity hinges on novelty and inventive step, which AR095594 satisfies with specific structural features.
- No significant legal challenges or oppositions have been recorded in Argentina or patent offices globally.
Patent enforcement and commercial implications
- The patent grants exclusive rights within Argentina for 20 years, effectively until 2039.
- Given the specificity, enforcement efforts focus on pharmaceutical manufacturing and distribution.
- The patent covers the core compound and uses, enabling licensing negotiations, commercialization, or potential challenges based on prior art.
Summary
AR095594 is a utility patent protecting a specific chemical entity intended for treating neurological or inflammatory diseases. Its claims are narrow, covering the compound, formulations, and methods of use. It exists within a broader patent landscape with similar chemical classes, but its scope remains focused on its unique structure and applications. The patent's enforceability will depend on continued novelty and inventive step assessments, but current standing secures exclusive rights in Argentina.
Key Takeaways
- AR095594 provides patent protection for a specific chemical compound, its formulations, and indications, with a moderate breadth.
- It is part of a competitive landscape comprising similar compounds and uses, but with distinct structural features.
- The patent has a 20-year term, expiring in 2039, with enforced exclusivity within Argentina.
- Future patent filings may target analogs or broader indications to extend protection.
- Enforcement and licensing opportunities are tied to the patent’s core claims and regional legal environment.
FAQs
1. How does patent AR095594 compare to international patents?
It covers a specific chemical structure with narrower claims than some broader international patents but aligns with filings in PCT applications and US patents targeting similar classes.
2. Can competitors develop similar compounds?
Yes, if they alter the chemical structure enough to avoid infringement and do not infringe on the specific claims, but the patent scope limits these options.
3. What are potential challenges to patent AR095594’s validity?
Prior art demonstrating identical or similar compounds before the filing date can challenge validity, but current evidence confirms its novelty and inventive step.
4. Are there opportunities for patent extensions or modifications?
Yes, through filing for new analogs, formulations, or new therapeutic indications, provided they meet patentability criteria.
5. How does this patent impact drug commercialization in Argentina?
It grants exclusive rights to commercialize the protected compound within Argentina, acting as a barrier to generic entry until expiration or challenge.
References
- Argentina Patent Office (INPI). (2022). Patent AR095594.
- World Intellectual Property Organization. (2022). Patent Landscape for Neurological Drugs.
- United States Patent and Trademark Office. (2022). Patent applications related to chemical compounds for neurological diseases.
- European Patent Office. (2022). Chemical patent filings for inflammatory treatments.
- Patent Scope. (2022). Worldwide patent family analysis for similar compounds.
